Joseph Podolski Net Worth & Insider Trades

Joseph Podolski - President and CEO, Repros Therapeutics Inc

As of December 9, 2016

What is Joseph Podolski's Net Worth?

The current estimated net worth of Repros Therapeutics Inc's President and CEO, Joseph Podolski, is estimated to be about $2.57M . Joseph Podolski owns about 107,422 units of Repros Therapeutics Inc common stock. In the last 12 months at Repros Therapeutics Inc, Joseph Podolski has sold an estimated value of $0 worth.

What is Joseph Podolski's Past Insider Trading?

Joseph Podolski's largest purchase order was 20,000 units , worth over $32K on December 9, 2016. In total, Joseph Podolski has made about 3 transactions over 12 months of their time at Repros Therapeutics Inc. Joseph Podolski usually trades in December, February and January, with the busiest year in 2016.

JOSEPH PODOLSKI

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Joseph Podolski's' Mailing Address?

  • Mailing address is 2408 Timberloch Place Ste B1 Woodlands TX 77380 TX

Repros Therapeutics Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Pablo Legorreta Pablo Legorreta 2020 $55,674,558 $55,674,558 $55,674,558 $55,674,558
Pablo Legorreta Pablo Legorreta 2019 $28,545,792 $28,545,792 $28,545,792 $28,545,792
Terrance Coyne Terrance Coyne 2020 $3,395,000 $3,395,000 - $3,395,000
Terrance Coyne Terrance Coyne 2019 $1,925,625 $1,925,625 - $1,925,625
Christopher Hite 2020 $3,644,711 $3,644,711 $367,788 $3,644,711
Christopher Hite 2019 - - - -
George Lloyd George Lloyd 2020 $3,395,000 $3,395,000 - $3,395,000
George Lloyd George Lloyd 2019 $2,182,500 $2,182,500 - $2,182,500
James Reddoch, Ph.D. James Reddoch, Ph.D. 2020 $3,395,000 $3,395,000 - $3,395,000
James Reddoch, Ph.D. James Reddoch, Ph.D. 2019 $2,082,500 $2,082,500 - $2,082,500
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1802768/000114036121014879/nc10022939x1_def14a.htm

What are Repros Therapeutics Inc's Past Insider Trades?

Repros Therapeutics Inc's most recent insider trade came on February 27, 2023 by George W Lloyd who sold 25,000 units worth $931.66K . In the last 7 years, insiders at Repros Therapeutics Inc have sold an estimated value of $732.13M and bought an estimated value of $146.53M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are George W Lloyd, EVP,  James F Reddoch, EVP & Chief Scientific Officer,  and Rory B Riggs, Director .

REPROS THERAPEUTICS INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...